Advanced search
Publication Cover
Journal of Dermatological Treatment Volume 29, 2018 - Issue 1
Submit an article Journal homepage
282
Views
12
CrossRef citations to date
0
Altmetric
Psoriasis

Serum YKL-40 as a potential biomarker of inflammation in psoriasis

Anna BaranDepartment of Dermatology and Venereology, Medical University of Bialystok, Bialystok, Poland; Correspondence[email protected]
View further author information
,
Hanna MyśliwiecDepartment of Dermatology and Venereology, Medical University of Bialystok, Bialystok, Poland; View further author information
,
Malgorzata Szterling-JaworowskaDepartment of Dermatology and Venereology, Medical University of Bialystok, Bialystok, Poland; View further author information
,
Paulina KilukDepartment of Dermatology and Venereology, Medical University of Bialystok, Bialystok, Poland; View further author information
,
Magdalena ŚwiderskaDepartment of Infectious Diseases and Hepatology, Medical University of Bialystok, Bialystok, PolandView further author information
&
Iwona FlisiakDepartment of Dermatology and Venereology, Medical University of Bialystok, Bialystok, Poland; View further author information
Pages 19-23 | Received 15 Feb 2017, Accepted 01 May 2017, Published online: 30 May 2017

Citations (12)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Mohammed Abu El-Hamd, Moustafa Adam El Taieb, Abdallah Abdallah Mahmoud & Ola Mahmoud Samy. (2019) Serum YKL-40 in patients with psoriasis vulgaris treated by narrow-band UVB phototherapy. Journal of Dermatological Treatment 30:6, pages 545-548.
Read now
Yi Kong, Suhan Zhang, Xin Su, Daoquan Peng & Yuwen Su. (2019) Serum levels of YKL-40 are increased in patients with psoriasis: a meta-analysis. Postgraduate Medicine 131:6, pages 405-412.
Read now

Articles from other publishers (10)

Ummugulsum Can. 2022. Biomarkers in Nutrition. Biomarkers in Nutrition 767 785 .
Ummugulsum Can. 2022. Biomarkers in Nutrition. Biomarkers in Nutrition 1 20 .
Youssef A. Elnabawi, Michael S. Garshick, Michael Tawil, Tessa J. Barrett, Edward A. Fisher, Kristen Lo Sicco, Andrea L. Neimann, Jose U. Scher, James Krueger & Jeffrey S. Berger. (2021) CCL20 in psoriasis: A potential biomarker of disease severity, inflammation, and impaired vascular health. Journal of the American Academy of Dermatology 84:4, pages 913-920.
Crossref
Shrook A. Khashaba, Enayat Attwa, Nora Said, Samar Ahmed & Fathia Khattab. (2020) Serum YKL ‐40 and IL 17 in Psoriasis: Reliability as prognostic markers for disease severity and responsiveness to treatment . Dermatologic Therapy 34:1.
Crossref
Yungen Jiao, Yahong Qin, Zhengang Zhang, Hao Zhang, Haiwei Liu & Chen Li. (2020) Early identification of carotid vulnerable plaque in asymptomatic patients. BMC Cardiovascular Disorders 20:1.
Crossref
Yingjian Deng, Guiyang Li, Dong Chang & Xin Su. (2020) YKL-40 as a novel biomarker in cardio-metabolic disorders and inflammatory diseases. Clinica Chimica Acta 511, pages 40-46.
Crossref
Dhanesh Amarnani, Angie V. Sanchez, Lindsay L. Wong, Brandon V. Duffy, Leslie Ramos, Suzanne K. Freitag, Diane R. Bielenberg, Leo A. Kim & Nahyoung Grace Lee. (2020) Characterization of a Murine Model of Oxazolone-Induced Orbital Inflammation. Translational Vision Science & Technology 9:8, pages 26.
Crossref
Katarzyna Winsz-Szczotka, Kornelia Kuźnik-Trocha, Anna Gruenpeter, Magdalena Wojdas, Klaudia Dąbkowska & Krystyna Olczyk. (2020) Association of Circulating COMP and YKL-40 as Markers of Metabolic Changes of Cartilage with Adipocytokines in Juvenile Idiopathic Arthritis. Metabolites 10:2, pages 61.
Crossref
In Jun Yeo, Chong-Kil Lee, Sang-Bae Han, Jaesuk Yun & Jin Tae Hong. (2019) Roles of chitinase 3-like 1 in the development of cancer, neurodegenerative diseases, and inflammatory diseases. Pharmacology & Therapeutics 203, pages 107394.
Crossref
Stephen Hu & Cheng-Che E. Lan. (2017) Psoriasis and Cardiovascular Comorbidities: Focusing on Severe Vascular Events, Cardiovascular Risk Factors and Implications for Treatment. International Journal of Molecular Sciences 18:10, pages 2211.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.